Jeff Van Sinderen's questions to Joint Corp (JYNT) leadership • Q2 2025
Question
Jeff Van Sinderen of B. Riley Securities asked about the strategy to lean more into pain management, including adding new products or services, the timeline for completing the refranchising of remaining corporate clinics, and which Regional Developer (RD) rights are still outstanding.
Answer
CEO Sanjiv Razdan stated the company is using pain-focused messaging to attract patients and will explore new products and services as part of its 'Joint 3.0' evolution, expected in about 12 months. He reiterated the goal to become a pure-play franchisor by the end of 2025 and noted that 15 Regional Developers covering 52% of the system remain, with buybacks being considered opportunistically.